Cervical Cancer

 

 

​Cervical cancer usually develops slowly over time. Before cancer appears in the cervix, the cells of the cervix go through changes known as dysplasia, in which abnormal cells begin to appear in the cervical tissue. Those abnormal cells may become cancer cells and start to grow and spread more deeply into the cervix and to surrounding areas.

Infection of the cervix with human papillomavirus (HPV) is almost always the cause of cervical cancer. Not all women with HPV infection, however, will develop cervical cancer. Women who do not regularly have tests to detect HPV or abnormal cells in the cervix are at increased risk of cervical cancer. The vast majority of cervical cancers could be prevented with Pap tests and HPV vaccination.

Cervical cancer, an often preventable cancer, will be diagnosed in an estimated 13,170 women living in the United States and some 4,250 women are expected to die of the disease in 2019, according to federal statistics.

Source: National Cancer Institute

 


The AACR - Impacting Cancer Research and Care

Reducing the Burden of Cervical Cancer

Improving the rates of cervical cancer screening and HPV vaccination could have significant benefits on this form of cancer.  Read More.

Study: On HPV Vaccines, the Message Matters

Researchers find some U.S. physicians "are missing many opportunities to protect today's young people from future HPV-related cancers."  Read More.

The American Association for Cancer Research (AACR) is a 501c3 registered nonprofit organization with offices at 615 Chestnut Street, 17th Floor, Philadelphia, PA 19106 | 215.440.9300